Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether use of blood pressure lowering drugs,
Angiotensin converting enzyme inhibitors (ACEIs) and blood fat (lipid) lowering drugs
(statins) may have a place in the treatment of adolescents with diabetes and can help reduce
serious long-term health problems in this population.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cambridge
Collaborators:
British Heart Foundation Diabetes UK Juvenile Diabetes Research Foundation Pfizer St Thomas' Hospital, London The Hospital for Sick Children The University of Western Australia University of Oxford